thanks for posting the article. I don’t think CSL will have anything to be concerned about. I do think the article however is a hatchet job on Aegros. Interviewing so called experts who don’t have any clue as to the intimacy of the technology as they are using a different process entirely(Cohn) . The Aegros technology has evolved and testament to this is the additional hyper immune products they can derive from the plasma.
Aegros have some fantastic people (operations, R&d ,scientific advisory) with depth and I am confident this business will succeed.
I am a shareholder in Aegros
Csl sounds pretty safe, page-4
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$283.05 |
Change
3.470(1.24%) |
Mkt cap ! $136.7B | |||
| Open | High | Low | Value | Volume |
| $281.90 | $284.50 | $281.02 | $168.3M | 594.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1012 | $283.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $283.47 | 3676 | 1 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$283.87 |
Change
3.470 ( 1.68 %) |
||||
| Open | High | Low | Volume | ||
| $282.06 | $284.50 | $281.58 | 26577 | ||
| Last updated 15.59pm 15/05/2024 ? | |||||
| CSL (ASX) Chart |